GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 45 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $80,000 | -10.1% | 81,235 | +3.0% | 0.00% | – |
| Q3 2016 | $89,000 | -23.3% | 78,879 | -0.1% | 0.00% | – |
| Q2 2016 | $116,000 | +38.1% | 78,955 | +33.8% | 0.00% | – |
| Q1 2016 | $84,000 | -19.2% | 58,988 | -6.6% | 0.00% | – |
| Q4 2015 | $104,000 | -25.7% | 63,170 | +5.9% | 0.00% | – |
| Q3 2015 | $140,000 | -16.2% | 59,664 | -2.6% | 0.00% | – |
| Q2 2015 | $167,000 | -90.5% | 61,242 | -88.3% | 0.00% | – |
| Q1 2015 | $1,749,000 | -0.2% | 522,204 | +3.4% | 0.00% | – |
| Q4 2014 | $1,752,000 | -19.9% | 505,022 | +16.1% | 0.00% | -100.0% |
| Q3 2014 | $2,188,000 | -65.1% | 434,998 | -4.1% | 0.00% | -50.0% |
| Q2 2014 | $6,262,000 | +568.3% | 453,412 | +640.9% | 0.00% | – |
| Q1 2014 | $937,000 | +150.5% | 61,201 | +32.1% | 0.00% | – |
| Q4 2013 | $374,000 | -15.6% | 46,340 | +4.4% | 0.00% | – |
| Q3 2013 | $443,000 | +159.1% | 44,400 | +10.6% | 0.00% | – |
| Q2 2013 | $171,000 | – | 40,161 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 169,578 | $222,000 | 0.08% |
| Geneos Wealth Management Inc. | 478,067 | $626,000 | 0.03% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $16,000 | 0.01% |
| Atria Wealth Solutions, Inc. | 281,700 | $369,000 | 0.01% |
| Vivaldi Capital Management LP | 17,078 | $22,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,284,481 | $1,684,000 | 0.00% |
| Ameritas Advisory Services, LLC | 45,302 | $59,000 | 0.00% |
| CENTAURUS FINANCIAL, INC. | 20,947 | $27,000 | 0.00% |
| Summit Trail Advisors, LLC | 23,855 | $31,000 | 0.00% |
| WEDBUSH SECURITIES INC | 27,998 | $37,000 | 0.00% |